GlassScriptPhysician profile
James Bearden
NPI 1447256730
$11,461.67
in general payments reported to CMS, 2019-2025
64 companies · $1,433 in 2025
The $1,433 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,661 · 2020: $524 · 2021: $1,419 · 2022: $1,709 · 2023: $2,739 · 2024: $1,976 · 2025: $1,433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,990 · Education: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,990.47 |
| Education | $157.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,157.46 | 2019-2025 | Enhertu, Tagrisso, Lynparza |
| Janssen Biotech, INC. | $1,026.60 | 2019-2025 | Imbruvica, Darzalex, Carvykti |
| Novartis Pharmaceuticals Corporation | $779.05 | 2019-2025 | Kisqali, Piqray |
| E.R. Squibb & Sons, L.L.C. | $707.22 | 2019-2025 | Opdivo, Pomalyst, Opdualag |
| Gilead Sciences, INC. | $527.85 | 2021-2025 | Trodelvy |
| Pfizer INC. | $445.09 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $441.77 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Incyte Corporation | $440.63 | 2019-2024 | Pemazyre, Monjuvi, Jakafi |
| Genentech USA, INC. | $429.40 | 2019-2025 | Columvi, Polivy, Lunsumio |
| Eisai INC. | $382.48 | 2020-2025 | |
| Celgene Corporation | $381.63 | 2019-2025 | Reblozyl, Pomalyst, Opdivo |
| Genzyme Corporation | $360.38 | 2019-2024 | |
| Lilly USA, LLC | $332.19 | 2019-2024 | Jaypirca, Verzenio, Retevmo |
| Daiichi Sankyo INC. | $330.84 | 2020-2025 | Enhertu, Injectafer, Datroway |
| Amgen INC. | $298.11 | 2019-2023 | Lumakras, Xgeva, Vectibix |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beigene USA, INC. | $250.57 | 2021-2025 | Brukinsa |
| Inari Medical, INC. | $191.54 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Jazz Pharmaceuticals INC. | $182.34 | 2022-2023 | |
| Abbvie INC. | $174.69 | 2019-2024 | Venclexta |
| Array Biopharma INC | $173.27 | 2019-2025 | Braftovi, Mektovi, Tukysa |
| Astellas Pharma US INC | $155.61 | 2019 | |
| Seagen INC. | $127.27 | 2021-2023 | Tukysa, Adcetris |
| Servier Pharmaceuticals LLC | $123.94 | 2021-2025 | |
| Sobi, INC | $120.80 | 2024-2025 | |
| Global Blood Therapeutics, INC. | $112.60 | 2021 | |
| G1 Therapeutics, INC. | $108.19 | 2022-2023 | Cosela |
| Bayer Healthcare Pharmaceuticals INC. | $104.64 | 2019-2025 | |
| Glaxosmithkline, LLC. | $103.39 | 2023-2025 | Ojjaara, Jemperli, Zejula |
| Exelixis INC. | $96.24 | 2019-2025 | Cabometyx |
| Ipsen Biopharmaceuticals, INC | $83.07 | 2019-2024 | Somatuline Depot, Onivyde |
| Pharmacyclics LLC, An Abbvie Company | $80.22 | 2019-2023 | Imbruvica |
| Regeneron Healthcare Solutions, INC. | $78.96 | 2019-2024 | Libtayo |
| Alexion Pharmaceuticals, INC. | $72.66 | 2019-2022 | |
| Agios Pharmaceuticals, INC. | $69.43 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $68.28 | 2019-2024 | Alunbrig, Ninlaro |
| Tersera Therapeutics LLC | $66.26 | 2019-2022 | |
| Advanced Accelerator Applications | $60.68 | 2019 | |
| Stemline Therapeutics INC. | $57.38 | 2023-2024 | Orserdu |
| Kyowa Kirin, INC. | $55.74 | 2020-2024 | Poteligeo |
| Karyopharm Therapeutics INC. | $51.87 | 2022-2024 | Xpovio |
| Mirati Therapeutics, INC. | $51.45 | 2023-2024 | Krazati |
| Pharmaessentia USA Corporation | $44.29 | 2025 | Besremi |
| Lexicon Pharmaceuticals, INC. | $40.79 | 2019-2020 | |
| Adaptive Biotechnologies Corporation | $39.61 | 2023-2024 | Clonoseq |
| Aveo Pharmaceuticals, INC. | $38.21 | 2022-2025 | |
| Cti Biopharma Corp. | $37.59 | 2023 | Vonjo |
| Taiho Oncology, INC. | $33.63 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $32.51 | 2025 | Provenge |
| Rigel Pharmaceuticals, INC. | $31.95 | 2019-2023 | Tavalisse, Rezlidhia |
| Sirtex Medical INC | $27.92 | 2019 | |
| Amag Pharmaceuticals, INC. | $27.24 | 2019 | |
| Clovis Oncology, INC. | $25.37 | 2019 | |
| Geron Corporation | $25.26 | 2025 | Rytelo |
| Epizyme, INC. | $23.28 | 2022 | |
| Azurity Pharmaceuticals, INC. | $21.74 | 2024 | Vivimusta |
| Beone Medicines USA, INC. | $20.20 | 2025 | Brukinsa |
| Syndax Pharmaceuticals, INC. | $19.06 | 2025 | |
| Novocure INC. | $18.15 | 2024 | Optune |
| Emd Serono, INC. | $17.01 | 2023 | Tepmetko |
| Springworks Therapeutics, INC. | $16.96 | 2024 | Ogsiveo |
| Adc Therapeutics America, INC. | $16.75 | 2025 | |
| Recordati_rare_diseases_inc. | $15.53 | 2023 | Sylvant |
| Dova Pharmaceuticals | $15.26 | 2020 | |
| Puma Biotechnology, INC. | $11.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bearden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.